Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.
Meritsi A, Latsou D, Manesis E, Gatos I, Theotokas I, Zoumpoulis P, Rapti S, Tsitsopoulos E, Moshoyianni H, Manolakopoulos S, Pektasides D, Thanopoulou A.
Meritsi A, et al. Among authors: gatos i.
Clin Diabetes. 2022 Summer;40(3):327-338. doi: 10.2337/cd21-0104.
Clin Diabetes. 2022.
PMID: 35983425
Free PMC article.